What is Fulcrum Therapeutics, Inc. Common Stock's Market Cap?

Fulcrum Therapeutics, Inc. Common Stock's Market Cap is $291.5M, based on as-reported figures from SEC (XBRL) filings.

What is Fulcrum Therapeutics, Inc. Common Stock's Revenue (TTM)?

Fulcrum Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Fulcrum Therapeutics, Inc. Common Stock's Net Income (TTM)?

Fulcrum Therapeutics, Inc. Common Stock's Net Income (TTM) is -$85.0M, based on as-reported figures from SEC (XBRL) filings.

What is Fulcrum Therapeutics, Inc. Common Stock's EBITDA?

Fulcrum Therapeutics, Inc. Common Stock's EBITDA is -$94.8M, based on as-reported figures from SEC (XBRL) filings.

What is Fulcrum Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Fulcrum Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.

Fulcrum Therapeutics, Inc. Common Stock (FULC) Financial Statements

Fulcrum Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00DDY1RM7

XNAS · usd

3.82▼ 0.03 (-0.78%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close3.85

Day's Range3.80 – 3.85

52-Week Range2.83 – 15.74

Volume1.1M

Avg Volume1.7M

Share Statistics

Shares Outstanding

Employees55

ExchangeXNAS

Listed2019-07-18

Share count as of July 23, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Fulcrum Therapeutics, Inc. Common Stock (FULC)

What is Fulcrum Therapeutics, Inc. Common Stock's Market Cap?: Fulcrum Therapeutics, Inc. Common Stock's Market Cap is $291.5M, based on as-reported figures from SEC (XBRL) filings.
What is Fulcrum Therapeutics, Inc. Common Stock's Revenue (TTM)?: Fulcrum Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Fulcrum Therapeutics, Inc. Common Stock's Net Income (TTM)?: Fulcrum Therapeutics, Inc. Common Stock's Net Income (TTM) is -$85.0M, based on as-reported figures from SEC (XBRL) filings.
What is Fulcrum Therapeutics, Inc. Common Stock's EBITDA?: Fulcrum Therapeutics, Inc. Common Stock's EBITDA is -$94.8M, based on as-reported figures from SEC (XBRL) filings.
What is Fulcrum Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Fulcrum Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.